Patents Examined by Peter G O'Sullivan
  • Patent number: 7550630
    Abstract: A process for producing N-(bicyclo[2.2.1]hept-5-en-2-ylmethyl)-1,1,1-trifluoromethanesulfonamide represented by formula [3]. The process includes the step of reacting trifluoromethanesulfonic anhydride with 1-bicyclo[2.2.1]hept-5-en-2-ylmethanamine in the presence of water and in the presence of a base selected from the group consisting of alkali metal hydroxides, alkaline-earth metal hydroxides and basic salts containing an alkali metal or an alkaline-earth metal.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: June 23, 2009
    Assignee: Central Glass Company, Limited
    Inventors: Kei Matsunaga, Takeo Komata
  • Patent number: 7547716
    Abstract: A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the general formula (I) or a physiologically acceptable salt thereof: wherein R represents an aryl-substituted alkyl group, an heteroaryl-substituted alkyl group, a cycloalkyl-substituted alkyl group, or a cyclic hydrocarbon group wherein said cyclic hydrocarbon group may be saturated, partly saturated, or aromatic; or Z may bind to R to form a cyclic structure, Z represents a hydrogen atom or a C1 to C6 alkyl group. The medicament enhanced the effect of the cancer therapy and decreases a dose of an anticancer agent and/or radiation, and therefore, can reduce side effects resulting from the cancer therapy.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: June 16, 2009
    Assignee: Institute of Medicinal Molecular Design, Inc.
    Inventors: Susumu Muto, Masayuki Komukai, Akiko Itai
  • Patent number: 7544837
    Abstract: A method of dehydrogenating an amine-borane having the formula R1H2N—BH2R2 using base metal catalyst. The method generates hydrogen and produces at least one of a [R1HN—BHR2]m oligomer and a [R1N—BR2]n oligomer. The method of dehydrogenating amine-boranes may be used to generate H2 for portable power sources, such as, but not limited to, fuel cells.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: June 9, 2009
    Assignee: Los Alamos National Security, LLC
    Inventors: Johanna Marie Blacquiere, Richard Jeffrey Keaton, Ralph Thomas Baker
  • Patent number: 7541493
    Abstract: The invention relates to a process for preparing modafinil having a defined granulometry which comprises the steps of: a) preparing a solution of DMSAM; b) contacting the solution obtained with NH3 at a predetermined temperature and a predetermined stirring; and c) isolating the modafinil formed, wherein said temperature and said stirring are predetermined in order to obtain said defined granulometry.
    Type: Grant
    Filed: May 5, 2004
    Date of Patent: June 2, 2009
    Assignee: Cephalon France
    Inventor: Sébastien Rose
  • Patent number: 7528273
    Abstract: An aqueous process is described in which thiocarboxylate silane is produced from haloalkyl silane by reaction of the haloalkyl silane with an aqueous solution of thiocarboxylate salt in the presence of a catalytically effective amount of alkylguanidinium salt.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: May 5, 2009
    Assignee: Momentive Performance Materials Inc.
    Inventors: Tiberiu Ladislau Simandan, Thomas Link Guggenheim
  • Patent number: 7510657
    Abstract: The present invention is a method of preparing affinity ligands, which method comprises to provide a cyclic scaffold comprising a thiol group, a carbonyl group and an amine group; to derivatize the amine group of said scaffold with an electrophile that carries either a functionality capable of affinity interaction or a functionality capable of a second interaction with a target molecule; and to open up the derivatized scaffold and add an amine that carries either a functionality capable of a second interaction or a functionality capable of affinity interaction with a target molecule. The method provides provide affinity ligands, which are capable of affinity interaction as well as a second kind of interaction.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: March 31, 2009
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Jean-Luc Maloisel, Nicolas Thevenin
  • Patent number: 7498464
    Abstract: In a process and an apparatus for synthesizing urea which synthesize urea from ammonia and carbon dioxide, the operating condition can be grasped easily and with good accuracy. A process for synthesizing urea which includes: a reaction step of obtaining a urea synthesis solution which contains urea, unreacted ammonia, unreacted carbon dioxide and water by causing ammonia and carbon dioxide to react with each other; a stripping step of separating a gas mixture containing the unreacted ammonia and the unreacted carbon dioxide by stripping the urea synthesis solution by using at least a portion of raw material carbon dioxide; a condensing step of obtaining a condensed liquid by condensing the gas mixture in an absorbing medium while cooling the gas mixture; a recycling step of recycling the condensed liquid to the reaction step; and a step of measuring the density of the condensed liquid online. An apparatus for carrying out this process is provided.
    Type: Grant
    Filed: May 30, 2006
    Date of Patent: March 3, 2009
    Assignee: Toyo Engineering Corporation
    Inventor: Yasuhiko Kojima
  • Patent number: 7449602
    Abstract: A stilbene derivative compound having a specific substituent at the specific position thereof to exert good compatibility with a binder resin and to tend to be uniformly dispersed in a photoconductive layer so as to allow prolonged specified sensitive property, a process for the production thereof, and an electrophotographic photoconductor containing the stilbene derivative compound are provided. For preparing a stilbene derivative compound represented by the general formula (1), a specified formylated triphenylamine derivative compound and a specified diphosphate ester derivative compound are allowed to be reacted with each other in the presence of a catalyst.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: November 11, 2008
    Assignee: Kyocera Mita Corporation
    Inventors: Tetsuya Ichiguchi, Yoshio Inagaki
  • Patent number: 7449596
    Abstract: A process for preparing a synthetic petroleum sulfonate comprising (a) reacting at least one aromatic compound with a mixture of olefins selected from olefins having from about 8 to about 100 carbon atoms, in the presence of an acidic ionic liquid catalyst, wherein the resulting product comprises at least about 50 weight percent of a 1,2,4 tri-substituted aromatic compound or a 1,2,3 tri-substituted aromatic compound or mixtures thereof; (b) reacting the product of (a) with sulfur trioxide, which has been diluted with air; and (c) neutralizing the product of (b) with an alkali or alkaline earth metal hydroxide.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: November 11, 2008
    Assignee: Chevron Oronite Company LLC
    Inventors: Curt B. Campbell, Thomas V. Harris, Gilles Sinquin
  • Patent number: 7442840
    Abstract: The present invention relates to a process for preparing severely sterically hindered secondary amine ether alcohols and diamine polyalkenyl ethers by reacting a primary amino compound with a polyalkenylether glycol in the presence of a high activity nickel powder hydrogenation catalyst which is marked by high conversion of reactants and increased selectivity to desired final product.
    Type: Grant
    Filed: February 1, 2005
    Date of Patent: October 28, 2008
    Assignee: ExxonMobil Research and Engineering Company
    Inventors: Christine Nicole Elia, Michael Siskin, Michael Charles Kerby, Adeana Richelle Bishop, Edmund John Mozeleski, Andrzej Malek
  • Patent number: 7439356
    Abstract: The present invention relates to intermediates of the formula useful in the preparation of piperazinyl-substituted indan derivatives, wherein Y is CONR2 wherein R2 is H or C1-C6 alkyl; R3 is C1-C6 alkyl, C3-C6 cycloalkyl or (CH2)n-aryl, wherein aryl is phenyl or a heteroaromatic ring containing one or two heteroatoms selected from N, O and S and which may be mono- or di-substituted with R4 and/or R5, wherein R4 and R5 are as defined in the specification; and R9 is H, C1-C6 alkyl, C3-C6 cycloalkyl, OCF3, OCHF2, OCH2F, halogen, CN, CF3, OH, C1-C6 alkoxy, C1-C6 alkoxy-C1-C6 alkyl, NR6R7, SO3CH3, SO3CF3, SO2NR6R7, an unsubstituted or substituted heterocyclic or heteroaromatic ring containing one or two heteroatoms selected from N and O, wherein the substituent(s) is(are) C1-C6 alkyl; or COR8; wherein R6, R7 and R8 are as defined in the specification. The invention further relates to a process for the preparation of the intermediates.
    Type: Grant
    Filed: October 3, 2006
    Date of Patent: October 21, 2008
    Assignee: AstraZeneca AB
    Inventors: Stefan Berg, Lennart Florvall, Svante Ross, Seth-Olov Thorberg
  • Patent number: 7429680
    Abstract: Severely sterically hindered secondary aminoether alcohols are prepared by reacting an organic carboxylic acid or alkali metal salt of an organic carboxylic acid with a sulfonyl halide, a sulfuryl halide, a mixed sulfuryl ester halide or a mixed sulfuryl amide halide to yield a sulfonic-carboxylic anhydride compound which is then reacted with a dioxane to cleave the ring of the dioxane, yielding a cleavage product which cleavage product is then aminated with an alkylamine and hydrolyzed with base to yield the severely sterically hindered secondary aminoether alcohol.
    Type: Grant
    Filed: February 1, 2005
    Date of Patent: September 30, 2008
    Assignee: Exxonmobil Research and Engineering Company
    Inventors: Michael Siskin, Alan Roy Katritzky, Kostyantyn Mykolayevich Kirichenko
  • Patent number: 7417164
    Abstract: A novel class of compounds that includes HPTS-Cys-MA, and methods of making them are disclosed herein. The class of compounds including HPTS-Cys-MA are useful as fluorescent dyes for analyte detection.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: August 26, 2008
    Assignee: Glumetrics Inc.
    Inventor: Jeff T. Suri
  • Patent number: 7414156
    Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.
    Type: Grant
    Filed: January 20, 2005
    Date of Patent: August 19, 2008
    Assignee: Warner Lambert Co.
    Inventors: Garrett Stewart Hoge, II, Om Prakash Goel
  • Patent number: 7414130
    Abstract: In an integrated process for urea and melamine production, urea is produced in a urea plant (12) comprising a high pressure urea synthesis section (15) and a urea recovery section (16) for separating urea from a carbamate aqueous solution, and melamine is produced in a melamine plant (11) wherein off-gases resulting as byproducts of the melamine synthesis are discharged therefrom at a pressure of at least 2 bar and recycled to the high pressure urea synthesis section (15).
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: August 19, 2008
    Assignee: Urea Casale S.A.
    Inventors: Paolo Brunengo, Federico Zardi
  • Patent number: 7411087
    Abstract: The present invention provides a novel process for preparation of bisphosphonic acids or salts thereof, e.g. alendronic acid, by reacting a carboxylic acid, phosphorous acid and a halophosphorous compound in a water miscible neutral solvent.
    Type: Grant
    Filed: August 10, 2004
    Date of Patent: August 12, 2008
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Vijaykumar Muljibhai Patel, Trinadha Rao Chitturi, Rajamannar Thennati
  • Patent number: 7411002
    Abstract: Certain lipophilic polycationic sulfonamides are provided and are useful for treating various diseases or conditions and particularly sepsis.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: August 12, 2008
    Assignees: The University of Kansas, Mediquest Therapeutics, Inc.
    Inventors: Mark R. Burns, Sunil A. David, Scott A. Jenkins
  • Patent number: 7393874
    Abstract: The present invention relates to novel polymorphs of tolterodine tartrate, to processes for their preparation and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: April 8, 2003
    Date of Patent: July 1, 2008
    Assignee: Hetero Drugs Limited
    Inventors: Bandi Parthasaradhi Reddy, Kura Rathnakar Reddy, Rapolu Raji Reddy, Dasari Muralidhara Reddy, Kesireddy Subash Chander Reddy
  • Patent number: 7256204
    Abstract: A compound of the formula: wherein Ar is an aromatic ring assembly group which may be substituted or a fused aromatic group which may be substituted; X is (i) a bond, (ii) —S—, —SO— or —SO2—, (iii) C1-6 alkylene, C2-6 alkenylene or C2-6 alkynylene, etc.
    Type: Grant
    Filed: August 21, 2003
    Date of Patent: August 14, 2007
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kaneyoshi Kato, Jun Terauchi, Hiroaki Fukumoto, Mitsuru Kakihana
  • Patent number: 7208506
    Abstract: The present invention relates to compounds of formula I wherein R1, R2 and R3 are defined herein, their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: April 24, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Edward Boyd, Frederick Brookfield, Jonathan Gridley, Manfred Kubbies, Raymond Lau, Ulrike Reiff, Georg Tiefenthaler, Wolfgang von der Saal, Thomas von Hirschheydt, Timothy Woodcock